Docosahexaenoic Acid-Rich Fish Oil Supplementation Improves Body Composition without Influence of the PPARÎ³ Pro12Ala Polymorphism in Patients with Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.

Mansoori, Anahita; Sotoudeh, Gity; Djalali, Mahmoud; Eshraghian, Mohammad-Reza; Keramatipour, Mohammad; Nasli-Esfahani, Ensieh; Shidfar, Farzad; Alvandi, Ehsan; Toupchian, Omid; Koohdani, Fariba

Mansoori, Anahita; Sotoudeh, Gity; Djalali, Mahmoud; Eshraghian, Mohammad-Reza; Keramatipour, Mohammad; Nasli-Esfahani, Ensieh; Shidfar, Farzad; Alvandi, Ehsan; Toupchian, Omid; Koohdani, Fariba.

Affiliation

Mansoori A; Nutrition and Metabolic Diseases Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.

J Nutrigenet Nutrigenomics ; 8(4-6): 195-204, 2015.

Article in En | MEDLINE | ID: mdl-26836268

Subject(s)

Body Composition/drug effects; Diabetes Mellitus, Type 2/diet therapy; Diabetes Mellitus, Type 2/metabolism; Docosahexaenoic Acids/administration & dosage; Fish Oils/administration & dosage; PPAR gamma/genetics; Polymorphism, Genetic; Aged; Alanine/genetics; Amino Acid Substitution; Diabetes Mellitus, Type 2/genetics; Dietary Supplements; Double-Blind Method; Humans; Middle Aged; Placebos; Proline/genetics

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Polymorphism, Genetic / Body Composition / Fish Oils / Docosahexaenoic Acids / PPAR gamma / Diabetes Mellitus, Type 2 Type of study: Clinical_trials Language: En Journal: J Nutrigenet Nutrigenomics Year: 2015 Type: Article Affiliation country: Iran

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google